The proposed Canary Staked INJ ETF aims to provide institutional investors with regulated access to on-chain yield, reflecting growing confidence in Injective’s ecosystem.
Canary Capital has filed with the SEC to launch the first-ever staked Injective (INJ) ETF, which would actively stake its INJ holdings on the Injective proof-of-stake network, offering estimated annual staking rewards of 10% to 12% to shareholders. This initiative indicates increasing market confidence in Injective, supported by firms like Google Cloud and T-Mobile. The proposal is part of a broader strategy by Canary Capital to integrate high-yield digital assets into traditional financial markets, with ongoing discussions with U.S. regulators to ensure compliance in decentralized finance.